Literature DB >> 30894015

EGF (Epidermal Growth Factor) Receptor Ligands in Atrial Fibrillation: From Genomic Evidence to the Identification of New Players.

Petra Büttner1, Sarah Werner1, Philipp Sommer2, Ralph Burkhardt3,4, Samira Zeynalova5,4, Ronny Baber3,4, Andreas Bollmann2, Daniela Husser-Bollmann2,4, Joachim Thiery3,4, Gerhard Hindricks2, Holger Thiele1, Jelena Kornej2,5,4.   

Abstract

Entities:  

Keywords:  EGF; HB-EGF; atrial fibrillation; biomarker; cytokines; growth factors

Mesh：

Substances：

Year:  2019        PMID： 30894015     DOI： 10.1161/CIRCEP.119.007212

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN： 1941-3084


× No keyword cloud information.
  4 in total

1.  Mechanisms of Quercetin against atrial fibrillation explored by network pharmacology combined with molecular docking and experimental validation.

Authors:  Xin Tan; Wei Xian; Xiaorong Li; Yongfeng Chen; Jiayi Geng; Qiyi Wang; Qin Gao; Bi Tang; Hongju Wang; Pinfang Kang
Journal:  Sci Rep       Date:  2022-06-13       Impact factor: 4.996

2.  Ibrutinib Has Time-dependent On- and Off-target Effects on Plasma Biomarkers and Immune Cells in Chronic Lymphocytic Leukemia.

Authors:  Tom A Mulder; Lucía Peña-Pérez; Anna Berglöf; Stephan Meinke; H Yesid Estupiñán; Kia Heimersson; Rula Zain; Robert Månsson; C I Edvard Smith; Marzia Palma
Journal:  Hemasphere       Date:  2021-04-26

3.  Hub Genes Identification, Small Molecule Compounds Prediction for Atrial Fibrillation and Diagnostic Model Construction Based on XGBoost Algorithm.

Authors:  Lingzhi Yang; Yunwei Chen; Wei Huang
Journal:  Front Cardiovasc Med       Date:  2022-07-14

Review 4.  The two facets of receptor tyrosine kinase in cardiovascular calcification-can tyrosine kinase inhibitors benefit cardiovascular system?

Authors:  Ainun Nizar Masbuchin; Mohammad Saifur Rohman; Ping-Yen Liu
Journal:  Front Cardiovasc Med       Date:  2022-09-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.